RxDoctor Payments Data
★ My doctorsLook up a doctor →

Dipali Trivedi, MD

Medical Oncology · Winter Park, FLNPI 1407055973

Payments from drug & device makers

$14,697in general payments, 2019–2025

Across 173 payments — averaging $84.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tosoh Bioscience, Inc.$11K
  • Merck$300
  • Astellas Pharma US Inc$282
  • Bristol Myers Squibb$282
  • AbbVie$265
  • Novartis$238
  • plus $3K from 43 others

What the payments were for

  • Food & beverage$3,79026%
  • Education$951%
  • Gifts$10,81274%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Tosoh Bioscience, Inc.4$10,812
Merck12$300
Astellas Pharma US Inc12$282
Bristol Myers Squibb11$282
AbbVie11$265
Novartis11$238
Johnson & Johnson10$232
AstraZeneca(2 entities)7$171
Eisai Inc.5$127
Sanofi5$122
Beone Medicines USA, Inc.5$120
Dova Pharmaceuticals1$111
Pfizer6$108
Incyte Corporation5$100
Daiichi Sankyo Inc.5$98
Array Biopharma Inc6$98
ADC Therapeutics America, Inc.4$97
GSK4$83
Gilead(2 entities)3$83
Takeda Pharmaceuticals U.S.A., Inc.3$78
Sobi, Inc2$64
Pharmaessentia USA Corporation3$60
Servier Pharmaceuticals LLC3$58
Lilly USA, LLC2$54
E.r. Squibb & Sons, L.L.C.3$51
Bayer2$41
Tersera Therapeutics LLC2$41
EMD Serono, Inc.2$40
Iovance Biotherapeutics, Inc.2$38
Springworks Therapeutics, Inc.2$31
Dendreon Pharmaceuticals LLC1$29
Regeneron Healthcare Solutions, Inc.1$27
Pharmaand GmbH2$26
Menarini Silicon Biosystems, Inc.1$26
Taiho Oncology, Inc.1$25
Grifols USA, LLC1$25
Tolmar, Inc.1$25
Geron Corporation1$24
Alnylam Pharmaceuticals Inc.1$22
Pharmacosmos Therapeutics Inc.1$21
Deciphera Pharmaceuticals Inc.1$21
Beigene USA, Inc.1$21
Recordati_rare_diseases_inc.1$21
Fennec Pharmaceuticals, Inc.1$20
Genentech USA, Inc.1$19
Ipsen Biopharmaceuticals, Inc1$18
Pharmacyclics LLC, An Abbvie Company1$15
Stemline Therapeutics Inc.1$15
Puma Biotechnology, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,697 in reported general payments places this provider in the 45th percentile of 507 medical oncology providers in Florida.

See all medical oncology providers in Florida →

Medicare billing

Part B allowed, 2024
$474,209
Medicare patients
538
Services billed
25,711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Winter Park

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →